Skip to content

Genetic Variants and Perioperative Morbidity and Mortality

Genetic Variants and Perioperative Morbidity and Mortality

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02124499
Enrollment
20000
Registered
2014-04-28
Start date
2011-01-02
Completion date
2027-12-31
Last updated
2026-01-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Analgesia, Anesthesia, Surgical Procedure, Operative

Keywords

anesthesia recovery period, postoperative complications, pain, pain measurement, postoperative nausea and vomiting, quality of life, genetic association study

Brief summary

Prospective association study to analyse perioperative patients' outcome. Outcome comprises intraoperative and postoperative complications e.g. cardio-vascular events, allergic reactions, Possible variables which might have on influence: patient- and surgery-related data, patients' genetic background etc.

Detailed description

Background Anesthesia and surgery are related to unwanted adverse events, side effects and postoperative discomfort. Whereas severe complications like cardiovascular events are rare, postoperative side effects like nausea and vomiting, pain, long-lasting pain and pain related interference of daily activities are frequent. The question arises which patient is at specific risk for this sequelae. Pre-exiting predisposing factors (e.g. patients' genetic background), surgery and anesthesia related variables (drugs, techniques administered for anesthesia and analgesia) as well as psychological and social factors might influence the outcome. In this prospective association study these variables will be investigated in a well-described patient cohort presenting for elective surgery. Objective The aim of this study is to associate perioperative and postoperative complications and side effects as well as long-term outcome after surgery to patient- and surgery-related variables, including genetic variants. Methods Prospective association study performed in two independent patient cohorts.

Interventions

None listed

Sponsors

Insel Gruppe AG, University Hospital Bern
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* 18 years and older * Written informed consent * Scheduled surgery

Exclusion criteria

* No informed consent * Cognitive impairment

Design outcomes

Primary

MeasureTime frameDescription
Postoperative nausea and vomiting (PONV)Up to 48 hours after surgeryPercent of patients with no PONV, medium PONV and severe PONV PONV outcome measured by a composite score: number of episodes of vomiting + severity of nausea (NRS score) + need for antiemetic treatment Patients with no PONV are compared to those with intermediate and severe PONV

Secondary

MeasureTime frameDescription
Pain related impairment after surgeryup to 2 days after surgeryMeasured by the International Pain Outcomes Questionnaire
Pain related impairment of patients with chronic pain after surgery versus patients without chronic pain after surgeryup to one year after surgeryMeasured by the Brief Pain Inventory (BPI)
Cardio-vascular events after surgeryUp to 30 days after surgeryMeasured by a score for major adverse cardiac events (MACE)
Pain related impairment of patients with chronic neuropathic pain (DN4 positive) after surgery versus patients without neuropathic pain after surgeryup to one year after surgeryMeasured by the Brief Pain Inventory (BPI)
What influences pain related impairment after bariatric surgeryup to 1 year after surgeryMeasurement of patient reported outcome by the BPI (Brief Pain Inventory).

Countries

Switzerland

Contacts

Primary ContactUlrike M Stamer, Prof. MD
ulrike.stamer@dbmr.unibe.ch0041-316329995
Backup ContactMarkus Lüdi, MD
markus.luedi2@insel.ch0041-316323965

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026